Parexel launches IMPACT Express clinical trial management system

Published: 1-Dec-2015
Regulatory

Simplifies clinical trial management and monitoring for small-to-mid-sized biopharmaceutical companies


Parexel International, a global biopharmaceutical services provider, has introduced the IMPACT Express Clinical Trial Management System (CTMS), which simplifies clinical trial management and monitoring for small- to mid-sized biopharmaceutical companies.

The firm says a single, unified clinical trial management system can play a vital role in helping biopharmaceutical companies plan, track, record, and oversee the complex array of administrative, financial, site-related, and other activities that are critical for the efficient monitoring and management of clinical trials.

'Parexel developed IMPACT Express for biopharmaceutical and biotech companies in need of a scalable, rapid-to-deploy and cost-effective CTMS option to intelligently manage the complexities of clinical trials,' said Patrick Nadolny, Vice President of Product Management, Data and Analytics Services, Parexel Informatics. 'By applying a process-driven approach to trial management and monitoring, biopharma companies will be better able to save time – and money – while simplifying their drug development journey.'

  • Companies:
  • Parexel International
See more

You may also like

Regulatory

Innovation in clinical trials

Read more
Clinical trials have undergone significant technological and regulatory developments during the past decade; and now, following the rise of the IoT (Internet of Things), the pharma industry is poised for even more change

Trending Articles

  1. Accelerating and enhancing toxicology assessments Infographic guides users through ToxHQ’s speedy assessment features
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    Merck jumps on the GLP-1 therapeutic bandwagon by licensing Hansoh Pharma's HS-10535 Merck will be responsible for the development, manufacture and commercialisation of the investigational preclinical oral GLP-1 receptor agonist
  3. Bayer's acoramidis recommended for approval by the EMA's CHMP for cardiomyopathy The orally administered transthyretin (TTR) stabiliser is suitable for patients with transthyretin amyloid cardiomyopathy, demonstrating at least a 90% TTR stabilisation capacity and a reduction in cardiovascular-related hospitalisations
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    Why quality control should be intimately combined with sterile product development, manufacturing and the overall product supply chain With sponsor companies increasingly needing to create and launch differentiated, stable, usable and safe injectable treatments for patients, experts at ten23 health are keen to promote the importance of integrating development and/or manufacturing with quality control services
  5. The right validation model: practical considerations and applications It is widely accepted that validation in the life sciences industry follows a lifecycle model (1,2). What is not always clear is the specific model — or models — to follow and how to navigate through them in the real world. Hurdles to overcome include the specific deliverables that make up that model and how they change during the various interactions along the validation journey

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Regulatory

Innovation in clinical trials

Clinical trials have undergone significant technological and regulatory developments during the past decade; and now, following the rise of the IoT (Internet of Things), the pharma industry is poised for even more change
Regulatory

PAREXEL announces definitive agreement to acquire The Medical Affairs Company

Acquisition will strengthen and add scale to current commercialisation and medical affairs services
Regulatory

PAREXEL launches IDMP-focused software and service solution

Solution developed to help biopharmaceutical companies meet emerging regulatory requirements ahead of deadline
Regulatory

Parexel and EMC to provide cloud-based document and regulatory information management services

Parexel enhances Regulatory Cloud and leverages EMC Documentum for Life Sciences software to offer regulatory solution
Regulatory

Opinion: Between a rock and a hard place

The tragic death of a healthy volunteer in a Phase I clinical trial emphasises how little we really know about the human organism
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Incorporating CMOs into the clinical trial supply chain

The clinical supply chain involves working with several outsourced partners. Jens Mattuschka, Vice President, CLS Worldwide Operations, Parexel International, looks at core planning to reduce the risk of failure
Regulatory

Parexel acquires ClinIntel

Extending its clinical randomisation and trial supply management services
Subscribe now